BioSpace News Archive

Pharmaceutical waste includes unused, contaminated and expired pharmaceutical agents including biological products and vaccines used for therapy.

The National Disease Research Interchange (NDRI) has been awarded a research resource grant of $334,446 from the National Institute on Aging (NIA) to support the development of the Ocular Tissue Resource for Alzheimer’s Disease (OTRAD).

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Bio-Rad and 10x Genomics, Inc. (Nasdaq: TXG) have reached a final settlement to resolve multiple long-running litigations in Massachusetts, Delaware, California, Germany, and before the International Trade Commission.

Cardiac arrest is a medical emergency and can strike without warning and can be fatal if not treated quickly.

Over the years, the geriatric population around the world has grown continuously.

OraSure Technologies, Inc. has scheduled its regular earnings conference call covering 2021 second quarter financial results and certain business developments for 5:00 pm ET on Tuesday, August 3, 2021.

Augmedix, Inc. (OTCQX: AUGX), a leading provider of virtual medical documentation and live clinical support, today announced it will report financial results for the second quarter 2021 on Tuesday, August 10, 2021 after market close.

SOPHiA GENETICS SA, the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced the closing of its initial public offering of 13,000,000 ordinary shares at a price of $18 per share.

Sientra, Inc., a medical aesthetics company uniquely focused on plastic surgeons, announced that it will release financial results for the second quarter of 2021 after the close of trading on Tuesday, August 10, 2021.

NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced it plans to report second quarter financial results and provide a corporate update on Monday, August 9, 2021, via press release, after market close.